Startseite › Lungenkrebs › Kentucky › Lexington
Klinische Studien zu Lungenkrebs in Lexington, KY
18 Studien zu Lungenkrebs suchen Teilnehmer an Standorten in und um Lexington (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Teilnehmer gesuchtPhase 3
- Baptist Health Lexington, Lexington
- Baptist Health Hamburg, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Teilnehmer gesuchtPhase 2
- University of Kentucky Chandler Medical Center ( Site 0019), Lexington
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- CommonSpirit Saint Joseph Hospital - Lexington, Lexington
- Saint Joseph Radiation Oncology Resource Center, Lexington
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Teilnehmer gesuchtPhase 3
- University of Kentucky/Markey Cancer Center, Lexington
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Teilnehmer gesuchtPhase 2/3
- Baptist Health Lexington, Lexington
- University of Kentucky Chandler Medical Center, Lexington
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Teilnehmer gesuchtPhase 2/3
- Baptist Health Lexington, Lexington
- University of Kentucky Chandler Medical Center (UKCMC) - Markey Cancer Center (Lucille P. Markey Cancer Center), Lexington
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Teilnehmer gesuchtPhase 1/2
- University of Kentucky/Markey Cancer Center, Lexington
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Teilnehmer gesuchtPhase 3
- CHI Saint Joseph Cancer Center - East, Lexington
- University of Kentucky Chandler Medical Center, Lexington
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
Teilnehmer gesuchtPhase 2
- University of Kentucky ( Site 0019), Lexington
EXoPERT EMERALD Clinical Study
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Lexington VA Healthcare System, Lexington
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- University of Kentucky/Markey Cancer Center, Lexington
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment
Teilnehmer gesucht
- University of Kentucky, Lexington
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2
- University of Kentucky/Markey Cancer Center, Lexington
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Teilnehmer gesuchtPhase 2/3
- University of Kentucky/Markey Cancer Center, Lexington
Precision Lung Cancer Survivorship Care Intervention
Teilnehmer gesucht
- Markey Cancer Center, Lexington
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Teilnehmer gesuchtPhase 1
- University of Kentucky Markey Cancer Center, Lexington
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Baptist Lexington, Lexington
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Teilnehmer gesuchtBeobachtungsstudie
- Lexington VA Health Care System, Lexington
Lungenkrebs-Studien in anderen Städten
- Houston, TX78 Studien
- Boston, MA62 Studien
- New York City, NY60 Studien
- Los Angeles, CA45 Studien
- Washington, DC41 Studien
- Arlington, VA41 Studien
- Chicago, IL41 Studien
- Nashville, TN40 Studien
- Baltimore, MD40 Studien
- St. Louis, MO39 Studien
- Columbus, OH37 Studien
- Philadelphia, PA36 Studien
Weitere Studien in Lexington
- Nichtkleinzelliges Lungenkarzinom23 Studien
- Eierstockkrebs16 Studien
- Krebs (alle Arten)14 Studien
- Prostatakrebs14 Studien
- Brustkrebs14 Studien
- Metastasierender Krebs11 Studien
- Herzinsuffizienz11 Studien
- Kolorektales Karzinom11 Studien
- Adipositas10 Studien
- Akute myeloische Leukämie10 Studien
- Melanom10 Studien
- Bauchspeicheldrüsenkrebs9 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.